| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Venture Capital > Writing Grant Proposals that Win is Just the Beginning |
|
E-Folder - Writing Grant Proposals that Win is Just the Beginning
When I wrote my first grant proposals, I sat in my classroom brainstorming-- alone. I’d peruse the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product latest grant application and dream up appropriate, but complicated, enrichment activities for our s ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in udents. Saturday programs, life skills sessions, and excursions to Broadway would be the panaceas t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. transform the lives of young adults with disabilities. When I won grants for such projects, I bec here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe me a one-woman show. I had to figure out all the details required to pull it off. At times I had to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cajole my peers-- New York City schoolteachers, to take on yet another project. The principal was c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc pable, committed, over-extended, and knew how to delegate. She respected our ability to get it done easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi This increased my personal responsibility for implementing winning grants with integrity. When goo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ideas are valued and supported with foundation, corporate, or government funds, you have an obliga and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ion to spend the money well. Therein lies a valuable lesson. Grant money puts you under contract t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi : * Deliver what you’ve promised on time; * Maintain a high quality of service; * Tr ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ack occurrences and document the process; * Spend the money as outlined, and * dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Make formal requests to modify the budget, if necessary. Winning a grant is a natural high, but cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin that’s when the real work begins. Grants transform vision into reality. If you’re working and writi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen g for an organization, you’re part of a team. Grant writers must get buy-in from a team or group of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel supporters from the onset. Whether the team is comprised of staff members, a Board of Directors, a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust volunteer advisory committee, or community residents, engage these stakeholders in your planning pr y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products cess. That way, when you win the grant, you’ll have a cheering section and foot soldiers to carry o . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t the tasks. This will, without doubt, boost your chances of meeting your goals and objectives. It elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip will also conserve your energy-- enabling you to write and win grants without succumbing to burnout tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Setting a Goal to Overcome Organisational Inertia Deadly Reason for Business Failure- Refusing to Spend Money on Employee Training A Holistic Approach To Sales-Selling And Life: Part 1
|